References
- Kahl, B S.; Bailey, H H.; Smith, E P.; Turman, N.; Smith, J.; Werndli, J.; Williams, E C.; Longo, W L.; Kim, K M.; McGovern, J.; Jumonville, A. Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study.Cancer Investig. 2005, 23 (1), 13–18. [CSA]
- Borghaei, H.; Millenson, M.; Schilder, R.; Alden, M.; Rogatko, A.; Wang, H.; Padavic-Shaller, K.; Smith, M R. Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non-Hodgkin lymphoma.Cancer 2004, 101 (9), 2034–2041. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]